Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Solana Co-Founder: Solana Ecosystem Inefficiently Communicates, Suggests Multiple Entities, Including Solana Foundation

Solana Co-Founder: Solana Ecosystem Inefficiently Communicates, Suggests Multiple Entities, Including Solana Foundation

Bitget2024/09/24 12:31

Speaking on Platform X, Solana co-founder Anatoly Yakovenko likened the Solana ecosystem to a decentralized and decentralized Y Combinator, noting that the Solana ecosystem is characterized by “founders rather than developers”, “startups rather than projects”, and “engineering rather than research”. Yakovenko acknowledged that the Solana ecosystem suffers from communication inefficiencies due to its decentralized nature, suggesting that there are multiple entities such as Solana Labs, Anza, the Solana Foundation, Helius, Metaplex, Colosseum, Jito, and Triton.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11